Patents by Inventor Robert Ashman

Robert Ashman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUPPORT APPARATUS FOR USE WITH AN ELONGATE STRUCTURE
    Publication number: 20160160514
    Abstract: Embodiments of the innovation relate to a support apparatus for use with an elongate structure, such as a chimney. In one arrangement, the support apparatus includes a base configured to extend along both sides of a pitched roof surface, a set of vertical supports secured to the base and configured to be secured to the chimney, and a set of platforms connected to the set of vertical supports and configured to at least partially extend about the perimeter of the chimney. Each platform of the set of platforms is connected to a corresponding adjacent platform of the set of platforms.
    Type: Application
    Filed: September 1, 2015
    Publication date: June 9, 2016
    Inventor: Robert Ashman
  • Immunomodulatory oligonucleotides and methods of use therefor
    Patent number: 7879812
    Abstract: The present invention is drawn a new class of oligodeoxynucleotides (ODNs) that inhibit ODN-activation of Toll-like receptor (TLR)9. Particular 4-5 base extensions at the 5? and of the previously described core inhibitory ODN sequence enhances their inhibitory activity against human cells expressing human TLR9. Methods of use also are provided.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: February 1, 2011
    Assignee: University of Iowa Research Foundation
    Inventors: Robert Ashman, Petar Lenert
  • IMMUNOMODULATORY OLIOGONUCLEOTIDES AND METHODS OF USE THEREFOR
    Publication number: 20100081706
    Abstract: The present invention is drawn a new class of oligodeoxynucleotides (ODNs) that inhibit ODN-activation of Toll-like receptor (TLR) 9. Particular 4-5 base extensions at the 5? and of the previously described core inhibitory ODN sequence enhances their inhibitory activity against human cells expressing human TLR9. Methods of use also are provided.
    Type: Application
    Filed: August 4, 2008
    Publication date: April 1, 2010
    Applicant: University of Iowa Research Foundation
    Inventors: ROBERT ASHMAN, Petar Lenert